SARENA FRANCIS WILLARD (Chief Strategy Officer) reported 2 transactions at FIVE PRIME THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/26/2021ACC: 0001209191-21-014646
Officer· Chief Strategy Officer
Since Sep 2018
-6.75K
Net shares
Net seller
$169.3K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
6.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.10K
Price / share
$25.71
Trade value
$131.12K
% of position
3.9%
2/24/2021
131.34K→126.24K
Common Stock
Direct
Shares
−1.65K
Price / share
$23.08
Trade value
$38.15K
% of position
1.3%
2/25/2021
126.24K→124.59K
Total
Net shares
−6.75K
Net value
-$169.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2021 | F · Tax Withholding | −5.10K | $25.71 | $131.12K | 3.9% | 131.34K | 126.24K |
| Common Stock Direct | 2/25/2021 | F · Tax Withholding | −1.65K | $23.08 | $38.15K | 1.3% | 126.24K | 124.59K |
| Total | −6.75K | -$169.27K | ||||||
Derivative Transactions0
No derivative transactions reported